Wound Closure
0
Pipeline Programs
3
Companies
3
Clinical Trials
1 recruiting
0
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket
Competitive Landscape
3 companies ranked by most advanced pipeline stage
Johnson & JohnsonNEW BRUNSWICK, NJ
2 programs"STRATAFIX™ Symmetric" Knotless TissueN/A
STRATAFIX PDS and Monocryl suturePHASE_41 trial
Active Trials
UNION therapeuticsDenmark - Hellerup
1 program"STRATAFIX™ Symmetric" Knotless TissueN/A1 trial
Active Trials
Trial Timeline
Clinical trial activity over time
2021
2022
2023
2024
2025
2026
2027
Johnson & JohnsonSTRATAFIX PDS and Monocryl suture
Imbed BiosciencesMicrolyte DualGuard
UNION therapeutics"STRATAFIX™ Symmetric" Knotless Tissue
Clinical Trials (3)
Total enrollment: 397 patients across 3 trials
Evaluation of the Efficacy of STRATAFIX for Neurosurgical Cranial and Spine Procedures
Start: Nov 2025Est. completion: Dec 2026160 patients
Phase 4Recruiting
Safety Study of Microlyte DualGuard
Start: Aug 2026Est. completion: Aug 202753 patients
N/ANot Yet Recruiting
Symmetric on Total Knee Arthroplasty (TKA)
Start: Jun 2017Est. completion: May 2018184 patients
N/ACompleted
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
1 actively recruiting trials targeting 397 patients
3 companies competing in this space
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.